Compare · TMO vs VELO
TMO vs VELO
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Velo3D Inc. (VELO): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VELO operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 1072.3x VELO ($240.2M).
- Both names hit the wire about 7 times in the past 4 weeks.
- TMO has more recent analyst coverage (25 ratings vs 4 for VELO).
- Company
- Thermo Fisher Scientific Inc
- Velo3D Inc.
- Price
- -
- -
- Market cap
- $257.53B
- $240.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 7
- Recent ratings
- 25
- 4
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Velo3D Inc.
Velocity Acquisition Corp. intends to effect a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in digital transformation businesses. The company was incorporated in 2020 and is based in Ridgefield, Connecticut.
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
Latest VELO
- SEC Form 8-K filed by Velo3D Inc.
- Velo3D Announces Preliminary Third Quarter 2026 Revenue of Approximately $19.5 Million to $20.5 Million, Representing Year-over-Year Growth of Approximately 43% to 51%
- SEC Form 8-K filed by Velo3D Inc.
- SEC Form 3 filed by Velo3D Inc.
- VELO3D AND MEARS EXPAND CAPABILITIES WITH DEDICATED U.S. CU-NI PRODUCTION
- Velo3D Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
- Velo3D Strengthens Technology and Operations Leadership to Advance Production at Scale
- Velo3D Joins GIDEP, Adding a Quality and Supply-Chain Resource for Defense Programs
- Director Lloyd Jason Michael exercised 1,960 shares at a strike of $10.53, increasing direct ownership by 14% to 16,335 units (SEC Form 4)
- Director Krause Stefan exercised 1,960 shares at a strike of $10.53, increasing direct ownership by 15% to 15,370 units (SEC Form 4)